My Quote Request
No products added yet
6505-01-153-3966
20 Products
NDC51479-0018-01
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
NDC51479-0018-01
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
MFG
DURA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CAPREOMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPREOMYCIN SULFATE STERILE USP POWDER FORM 1GM VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML SIZE RUBBER-STOPPERED VIAL
Related Searches:
CAPASTAT SULFATE
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
CAPASTAT SULFATE
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CAPREOMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPREOMYCIN SULFATE STERILE USP POWDER FORM 1GM VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML SIZE RUBBER-STOPPERED VIAL
Related Searches:
NDC00002-1485-01
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
NDC00002-1485-01
CAPREOMYCIN SULFATE,USP
NSN, MFG P/N
6505011533966
NSN
6505-01-153-3966
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CAPREOMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPREOMYCIN SULFATE STERILE USP POWDER FORM 1GM VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML SIZE RUBBER-STOPPERED VIAL
Related Searches:
NDC00081-0865-78
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
NDC00081-0865-78
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: 2 TABLETS PER PACKET
TOTAL PRIMARY CONTAINER QUANTITY: 500
Related Searches:
SUDAFED
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
SUDAFED
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: 2 TABLETS PER PACKET
TOTAL PRIMARY CONTAINER QUANTITY: 500
Related Searches:
SUDAFED TABLETS
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
SUDAFED TABLETS
PSEUDOEPHEDRINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011533967
NSN
6505-01-153-3967
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 TABLETS
SPECIAL FEATURES: 2 TABLETS PER PACKET
TOTAL PRIMARY CONTAINER QUANTITY: 500
Related Searches:
FLEX-CARE
CONTACT LENS DISINFECTING AND RINSING SOLUTION
NSN, MFG P/N
6505011533969
NSN
6505-01-153-3969
FLEX-CARE
CONTACT LENS DISINFECTING AND RINSING SOLUTION
NSN, MFG P/N
6505011533969
NSN
6505-01-153-3969
MFG
ALCON LABORATORIES INC .
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: USE ON SOFT (HYDROPHILIC) AND GAS PERMEABLE CONTACT LENS
Related Searches:
NDC00065-0158-12
CONTACT LENS DISINFECTING AND RINSING SOLUTION
NSN, MFG P/N
6505011533969
NSN
6505-01-153-3969
NDC00065-0158-12
CONTACT LENS DISINFECTING AND RINSING SOLUTION
NSN, MFG P/N
6505011533969
NSN
6505-01-153-3969
MFG
ALCON LABORATORIES INC .
Description
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: USE ON SOFT (HYDROPHILIC) AND GAS PERMEABLE CONTACT LENS
Related Searches:
CYSTOSPAZ-M
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
CYSTOSPAZ-M
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
MFG
ALCON LABORATORIES INC WEBCON PRODUCTS DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.16 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 100
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 16.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.002 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.60 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.375 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES 0.375MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LEVSINEX TIMECAPS
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
LEVSINEX TIMECAPS
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
MFG
SCHWARZ PHARMA INC .
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.16 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 100
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 16.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.002 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.60 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.375 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES 0.375MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00091-3537-01
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
NDC00091-3537-01
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
MFG
SCHWARZ PHARMA INC .
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.16 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 100
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 16.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.002 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.60 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.375 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES 0.375MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00998-2260-10
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
NDC00998-2260-10
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
MFG
ALCON LABORATORIES INC WEBCON PRODUCTS DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.16 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 100
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 16.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.002 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.60 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.375 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES 0.375MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC61451-2260-01
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
NDC61451-2260-01
HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011533982
NSN
6505-01-153-3982
MFG
ALCON LABORATORIES INC WEBCON PRODUCTS DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.16 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 100
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 16.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.002 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 1.60 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.375 MILLIGRAMS HYOSCYAMINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYOSCYAMINE SULFATE EXTENDED-RELEASE CAPSULES 0.375MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-3294-50
FUROSEMIDE ORAL SOLUTION
NSN, MFG P/N
6505011533984
NSN
6505-01-153-3984
NDC00054-3294-50
FUROSEMIDE ORAL SOLUTION
NSN, MFG P/N
6505011533984
NSN
6505-01-153-3984
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE ORAL SOL 10 MG/ML 120ML
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACCOMPANIED BY GRADUATED DISPENSING SPOON
Related Searches:
NDC60432-0613-04
FUROSEMIDE ORAL SOLUTION
NSN, MFG P/N
6505011533984
NSN
6505-01-153-3984
NDC60432-0613-04
FUROSEMIDE ORAL SOLUTION
NSN, MFG P/N
6505011533984
NSN
6505-01-153-3984
MFG
MORTON GROVE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE ORAL SOL 10 MG/ML 120ML
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACCOMPANIED BY GRADUATED DISPENSING SPOON
Related Searches:
HYPOTEARS
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011534014
NSN
6505-01-153-4014
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT W/OPHTHALMIC TIP
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: W/OPHTHALMIC TIP
Related Searches:
HYPOTEARS SOLUTION
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011534014
NSN
6505-01-153-4014
HYPOTEARS SOLUTION
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011534014
NSN
6505-01-153-4014
MFG
IOLAB CORP IOLAB PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT W/OPHTHALMIC TIP
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: W/OPHTHALMIC TIP
Related Searches:
NDC58768-0130-15
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011534014
NSN
6505-01-153-4014
NDC58768-0130-15
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011534014
NSN
6505-01-153-4014
MFG
NOVARTIS OPHTHALMICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ARTIFICIAL TEARS SOLUTION 15ML BT W/OPHTHALMIC TIP
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: W/OPHTHALMIC TIP
Related Searches:
NDC00121-0677-16
TRICITRATES ORAL SOLUTION,USP
NSN, MFG P/N
6505011534026
NSN
6505-01-153-4026
NDC00121-0677-16
TRICITRATES ORAL SOLUTION,USP
NSN, MFG P/N
6505011534026
NSN
6505-01-153-4026
MFG
PHARMACEUTICAL ASSOCIATES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 334.000 MILLIGRAMS CITRIC ACID, MONOHYDRATE PER MILLILITER AND 550.000 MILLIGRAMS POTASSIUM CITRATE, MONOHYDRATE PER MILLILITER AND 500.000 MILLIGRAMS SODIUM CITRATE, DIHYDRATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRICITRATES ORAL SOLUTION USP 16OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 MEQ POTASSIUM; 1 MEQ SODIUM; AND 2 MEQ BICARBONATE PER ML
Related Searches:
NDC00575-0223-01
TRICITRATES ORAL SOLUTION,USP
NSN, MFG P/N
6505011534026
NSN
6505-01-153-4026
NDC00575-0223-01
TRICITRATES ORAL SOLUTION,USP
NSN, MFG P/N
6505011534026
NSN
6505-01-153-4026
MFG
WILLEN DRUG CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 334.000 MILLIGRAMS CITRIC ACID, MONOHYDRATE PER MILLILITER AND 550.000 MILLIGRAMS POTASSIUM CITRATE, MONOHYDRATE PER MILLILITER AND 500.000 MILLIGRAMS SODIUM CITRATE, DIHYDRATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRICITRATES ORAL SOLUTION USP 16OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 1 MEQ POTASSIUM; 1 MEQ SODIUM; AND 2 MEQ BICARBONATE PER ML
